|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 36.75 DKK | 0.00% |
|
+0.41% | +1.52% |
| 06-18 | Nordea raises target price for Lundbeck to DKK60 (57), reiterates buy rating | FW |
| 06-14 | H. Lundbeck A/S Presents Preliminary Phase II Part A Data for Asedebart in Cushing's Disease | CI |
Company Valuation: Lundbeck
Data adjusted to current consolidation scope
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 25,433 | 31,719 | 39,416 | 41,398 | 41,983 | - | - |
| Change | - | 24.72% | 24.27% | 5.03% | 1.41% | - | - |
| Enterprise Value (EV) 1 | 27,464 | 31,008 | 51,598 | 49,619 | 46,072 | 41,889 | 38,149 |
| Change | - | 12.91% | 66.4% | -3.84% | -7.15% | -9.08% | -8.93% |
| P/E | 13.5x | 14.2x | 13x | 13.4x | 9.62x | 9.44x | 10.1x |
| PBR | 1.24x | 1.47x | 1.64x | 1.72x | 1.51x | 1.36x | 1.25x |
| PEG | - | 0.7x | 0.3x | 8.5x | 0.2x | 4.86x | -1.53x |
| Capitalization / Revenue | 1.39x | 1.59x | 1.79x | 1.68x | 1.63x | 1.63x | 1.68x |
| EV / Revenue | 1.51x | 1.56x | 2.34x | 2.01x | 1.79x | 1.62x | 1.53x |
| EV / EBITDA | 5.89x | 5.49x | 8.13x | 6.3x | 5.7x | 5.18x | 4.98x |
| EV / EBIT | 9.63x | 9.71x | 15.8x | 9.41x | 7.65x | 6.81x | 6.61x |
| EV / FCF | 10.2x | 8.66x | 18.7x | 10.2x | 8.19x | 6.76x | 6.89x |
| FCF Yield | 9.83% | 11.5% | 5.35% | 9.8% | 12.2% | 14.8% | 14.5% |
| Dividend per Share 2 | 0.58 | 0.7 | 0.95 | 1.15 | 1.502 | 1.552 | 1.515 |
| Rate of return | 2.23% | 2.14% | 2.3% | 2.66% | 3.43% | 3.55% | 3.46% |
| EPS 2 | 1.93 | 2.31 | 3.17 | 3.22 | 4.547 | 4.635 | 4.329 |
| Distribution rate | 30.1% | 30.3% | 30% | 35.7% | 33% | 33.5% | 35% |
| Net sales 1 | 18,246 | 19,912 | 22,004 | 24,630 | 25,738 | 25,820 | 24,986 |
| EBITDA 1 | 4,663 | 5,652 | 6,347 | 7,881 | 8,078 | 8,090 | 7,657 |
| EBIT 1 | 2,852 | 3,195 | 3,270 | 5,275 | 6,020 | 6,153 | 5,773 |
| Net income 1 | 1,916 | 2,290 | 3,143 | 3,192 | 4,559 | 4,618 | 4,313 |
| Net Debt 1 | 2,031 | -711 | 12,182 | 8,221 | 4,089 | -93.58 | -3,834 |
| Reference price 2 | 26.05 | 32.76 | 41.32 | 43.16 | 43.76 | 43.76 | 43.76 |
| Nbr of stocks (in thousands) | 992,840 | 992,840 | 992,011 | 991,227 | 991,227 | - | - |
| Announcement Date | 2/7/23 | 2/7/24 | 2/5/25 | 2/4/26 | - | - | - |
1DKK in Million2DKK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 18.55x | 0.22x | 12.86x | 0.42% | 91.82B | ||
| 30.59x | 0.24x | 15.28x | 0.87% | 55.63B | ||
| 44.2x | 3.12x | 28.97x | 1.4% | 22.51B | ||
| 11.41x | 0.2x | 4.85x | 2.63% | 8.16B | ||
| 13.56x | 1.05x | 8.43x | 2.49% | 7.86B | ||
| 6.03x | 0.09x | 2.57x | 4.87% | 6.86B | ||
| 24.47x | 1.18x | 14.52x | 2.95% | 5.31B | ||
| 10.81x | 0.12x | 4.48x | 4.14% | 3.71B | ||
| 13.59x | - | - | 2.52% | 3.41B | ||
| Average | 19.25x | 0.78x | 11.49x | 2.48% | 22.81B | |
| Weighted average by Cap. | 23.66x | 0.60x | 14.37x | 1.13% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- HLUN B Stock
- LUN Stock
- Valuation Lundbeck
Select your edition
All financial news and data tailored to specific country editions
















